Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
24. Februar 2020 13:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
Endonovo Therapeutics Begins Process For Medical Reimbursements
20. Februar 2020 11:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced undertaking initial steps for obtaining medical...
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
13. Februar 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced Endonovo Therapeutics is collaborating with a Stanford...
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
10. Februar 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced their SofPulse® device is being evaluated at major...
Endonovo Therapeutics Reduces Debt
04. Februar 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") is pleased to announce the reduction of current liabilities and...
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30. Januar 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
27. Januar 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced initial sales of SofPulse® units into a VA hospital in...
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
14. Januar 2020 09:00 ET
|
Endonovo Therapeutics, Inc.
● This furthers Endonovo’s strategy to commercialize and protect its Electroceutical(s)® Los Angeles, CA, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or...
Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke
07. Januar 2020 08:30 ET
|
Endonovo Therapeutics, Inc.
Issuance of U.S. Patent No. 15217855 Further Bolsters Endonovo’s Intellectual Patent Portfolio Los Angeles, CA, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDVD /...
Endonovo Therapeutics Provides SofPulse® To All NFL Teams [Updated]
23. Dezember 2019 09:48 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDVD) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...